The impact of nutritional status and changes of body composition on the prognosis of metastatic renal cell carcinoma patients
-
Published:2023
Issue:1.2
Volume:70
Page:80-87
-
ISSN:1343-1420
-
Container-title:The Journal of Medical Investigation
-
language:en
-
Short-container-title:J. Med. Invest.
Author:
Ozaki Keisuke1, Fukawa Tomoya1, Daizumoto Kei1, Sasaki Yutaro1, Ueno Yoshiteru1, Tsuda Megumi1, Uchida Takayuki2, Kusuhara Yoshito1, Yamamoto Yasuyo1, Yamaguchi Kunihisa1, Takahashi Masayuki1, Kanayam Hiro-omi1
Affiliation:
1. Department of Urology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan 2. Department of Nutritional Physiology, Institute of Medical Nutrition, Tokushima University Graduate School, Tokushima, Japan
Publisher
University of Tokushima Faculty of Medicine
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference38 articles.
1. 1. Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini BI, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B, CheckMate 214 Investigators : Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma. N Engl J Med 378 : 1277-1290, 2018 2. 2. Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Souli?res D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T, KEYNOTE-426 Investigators : Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma. N Engl J Med 380 : 1116-1127, 2019 3. 3. Motzer RJ, Robbins PB, Powles T, Albiges L, Haanen JB, Larkin J, Mu XJ, Ching KA, Uemura M, Pal SK, Alekseev B, Gravis G, Campbell MT, Penkov K, Lee JL, Hariharan S, Wang X, Zhang W, Wang J, Chudnovsky A, di Pietro A, Donahue AC, Choueiri TK : Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma : biomarker analysis of the phase 3 JAVELIN Renal 101 trial. Nat Med 26 : 1733-1741, 2020 4. 4. Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK : Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents : results from a large, multicenter study. J Clin Oncol 27 : 5794-5799, 2009 5. 5. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, H?tterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC : ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36 : 11-48, 2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|